This inventor holds 1 USPTO granted patent. Top assignee: The City University of New York. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: The Innovations of Burton E. Tropp
Introduction
Burton E. Tropp is a notable inventor based in Manhasset Hills, NY (US). He has made significant contributions to the field of biochemistry, particularly in cholesterol biosynthesis. His work has implications for understanding and potentially treating cholesterol-related health issues.
Latest Patents
Tropp holds a patent for "In vivo inhibitors of cholesterol biosynthesis." This patent includes the compounds dialkyl esters of 5-carbo[etiocholane-3'.alpha.-7'.alpha., 12'.alpha.-trihydroxy-17'.beta.(1' methyl-4' butyl]oxy-4-hydroxy-4-methylpentyl-1-phosphonate and 5-carbohexadecyloxy-4-hydroxy-4-methylpentyl-1-phosphonate. These compounds have been shown to inhibit cholesterol biosynthesis in rat liver cells, providing a foundation for further research in this area.
Career Highlights
Tropp is affiliated with the City University of New York, where he has contributed to academic research and innovation. His work has been recognized for its potential impact on health and medicine.
Collaborations
Some of his notable coworkers include Robert R. Engel and Virender K. Sarin. Their collaborative efforts have likely enhanced the research and development of cholesterol biosynthesis inhibitors.
Conclusion
Burton E. Tropp's contributions to the field of biochemistry through his patent on cholesterol biosynthesis inhibitors highlight the importance of innovation in health-related research. His work continues to inspire further exploration in this critical area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile